Explore Biodexa Pharmaceuticals PLC's February 2025 Form 6-K report, detailing key updates, including a significant press release and company activities impacting investors.
Explore Biodexa Pharmaceuticals PLC's latest financial report (Form 6-K) filed on February 13, 2025, detailing compliance, annual reporting, and recent press releases.
Explore key insights from Biodexa Pharmaceuticals PLC's Form 6-K report dated February 10, 2025, detailing company disclosures, legal disclaimers, and executive signature.
Biodexa Pharmaceuticals PLC's latest report details a $35 million securities purchase agreement with C/M Capital. Discover key terms, pricing, and strategic implications for growth.
Explore Biodexa Pharmaceuticals PLC's December 2024 Form 6-K filing, detailing a $600K promissory note issuance, new governance articles, and key financial insights.